Stock ScreenerStock IdeasStrong Buys According to Wall StreetStrong Buys According to Wall StreetCompanies with high upside and a consensus strong buy recommendation from Wall Street analysts
Stock ScreenerStock IdeasStrong Buys According to Wall Street
Consensus: Strong Buy
Analysts: >= 3
Upside/Downside: Large Upside
| Ticker | Company | Exchange | Industry | Zen Score | Market Cap | Price | 1d % | EBITDA | P/E | D/E |
|---|---|---|---|---|---|---|---|---|---|---|
| ATNM | ACTINIUM PHARMACEUTICALS INC | NYSEMKT | Biotechnology | $291.88M | $9.80 | -0.51% | -$45.63M | -5.73x | 1.02 | |
| CRGX | CARGO THERAPEUTICS INC | NASDAQ | Biotechnology | $804.06M | $20.42 | -4.31% | N/A | N/A | 0.13 | |
| PYXS | PYXIS ONCOLOGY INC | NASDAQ | Biotechnology | $244.39M | $4.15 | -0.48% | -$54.27M | -3.05x | 0.20 | |
| CWH | CAMPING WORLD HOLDINGS INC | NYSE | Auto & Truck Dealerships | $1.73B | $20.52 | -2.01% | $358.79M | 146.57x | 49.20 | |
| CTNM | CONTINEUM THERAPEUTICS INC | NASDAQ | Biotechnology | $398.71M | $15.50 | 3.61% | N/A | N/A | -0.09 | |
| IREN | IRIS ENERGY LTD | NASDAQ | Capital Markets | $833.24M | $6.02 | 3.26% | N/A | N/A | 0.07 | |
| EYPT | EYEPOINT PHARMACEUTICALS INC | NASDAQ | Biotechnology | $616.68M | $11.84 | -5.43% | -$77.74M | -6.54x | 0.32 | |
| ANNX | ANNEXON INC | NASDAQ | Biotechnology | $400.15M | $4.33 | -0.69% | -$117.42M | -2.97x | 0.16 | |
| ALXO | ALX ONCOLOGY HOLDINGS INC | NASDAQ | Biotechnology | $740.34M | $14.21 | -3.07% | -$163.76M | -3.83x | 0.30 | |
| ACHR | ARCHER AVIATION INC | NYSE | Aerospace & Defense | $1.20B | $3.70 | -2.89% | -$466.10M | -2.28x | 0.35 | |
| VKTX | VIKING THERAPEUTICS INC | NASDAQ | Biotechnology | $7.39B | $67.00 | -2.98% | -$93.43M | -72.04x | 0.04 | |
| PBPB | POTBELLY CORP | NASDAQ | Restaurants | $260.52M | $8.73 | -0.80% | $45.57M | 62.36x | 14.91 | |
| RZLT | REZOLUTE INC | NASDAQ | Biotechnology | $105.96M | $2.64 | 3.13% | -$57.66M | -2.32x | 0.24 | |
| STRO | SUTRO BIOPHARMA INC | NASDAQ | Biotechnology | $328.00M | $4.01 | -3.37% | -$75.58M | -2.13x | 3.12 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.